Moderna's New Vaccine Boosts Shares 1.33%!

miércoles, 4 de junio de 2025, 6:08 am ET1 min de lectura
MRNA--
Moderna, Inc. rose 1.33% in premarket trading. The company introduced mNEXSPIKE, a new COVID-19 vaccine, which could potentially reduce the burden of disease from COVID-19. Additionally, Moderna's pipeline programs, including Phase 3 readouts and potential product launches, are anticipated to reach upcoming milestones.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios